HCA Healthcare, Inc. - HCA STOCK NEWS

HCA Healthcare presented its annual Awards of Distinction, honoring exceptional employees, physicians, and volunteers. The awards include the Frist Humanitarian Award, the HCA Healthcare Innovators Award, and the Excellence in Nursing Award.

The Frist Humanitarian Award recipients are Samantha McClelland (employee), Dr. Jonathan Jacobs (physician), and Paulette Bennett (volunteer). Each demonstrated extraordinary commitment to serving others.

Jedediah Vivio received the Innovators Award for his work on the Expanse Automation team, contributing to HCA Healthcare's new electronic health record platform.

The Excellence in Nursing Award recipients are Roni S. Hutson for Professional Mentoring and Heather Hurlburt for Compassionate Care. Both nurses have shown exceptional dedication to patient care and professional development.

These awards reflect HCA Healthcare's commitment to recognizing individuals who exemplify the organization's culture and values.

HCA Healthcare, Inc. (NYSE: HCA) is set to participate in two major healthcare conferences in September 2024. The company will present at the 2024 Wells Fargo Healthcare Conference on September 5 at 8:00 AM ET in Everett, MA. Later that day, at 3:20 PM ET, HCA will also present at Morgan Stanley's 22nd Annual Global Healthcare Conference in New York, NY.

Investors and interested parties can access live audio webcasts and presentation materials through the Investor Relations section of HCA Healthcare's website. The company advises checking the conference schedule or their website for any potential changes to dates and times. These presentations offer valuable opportunities for stakeholders to gain insights into HCA Healthcare's operations and future strategies.

HCA Healthcare's subsidiary, HCA Inc., has announced a proposed public offering of senior notes. The terms, including maturity, interest rate, and principal amount, will be determined based on market conditions at pricing. The net proceeds are intended for general corporate purposes, potentially including repayment of borrowings under the company's senior secured asset-based revolving credit facility. Citigroup Global Markets, BofA Securities, J.P. Morgan Securities, and Wells Fargo Securities are acting as joint book-running managers for the offering. The offering is being made through an effective shelf registration statement filed with the SEC, with details available in the preliminary prospectus supplement and accompanying prospectus.

HCA Healthcare (NYSE: HCA) reported strong Q2 2024 results, with revenues reaching $17.492 billion, up from $15.861 billion in Q2 2023. Net income rose to $1.461 billion ($5.53 per diluted share), compared to $1.193 billion ($4.29 per diluted share) in Q2 2023. Adjusted EBITDA increased to $3.550 billion from $3.056 billion year-over-year.

Key metrics showed positive trends: same facility admissions up 5.8%, equivalent admissions up 5.2%, and emergency room visits up 5.5%. The company has raised its 2024 guidance, projecting revenues between $69.750 to $71.750 billion and EPS between $21.60 to $22.80 per diluted share.

HCA Healthcare, Inc. (NYSE: HCA) will host its 2nd Quarter 2024 Earnings Release Conference Call on Tuesday, July 23, 2024, at 9:00 am Central Time (10:00 am Eastern Time). Investors and interested parties can listen to the live audio webcast through the company’s investor relations website.

The webcast will be accessible at this link. For those unable to join live, the call will be archived on the same site.

For more information, contact Frank Morgan, Vice President, Investor Relations, at 615-344-2688 or via email at frank.morgan@hcahealthcare.com. Media inquiries can be directed to Harlow Sumerford at 615-344-1851.

HCA Healthcare announced that its foundation will donate $1 million over the next three years to the Consortium of Florida Education Foundations to support the Career Pathways to a Healthier Florida program.

The program focuses on creating and expanding healthcare career pathways for underserved high school students in Florida. This initiative comes in response to a projected shortage of 463,000 healthcare workers by the end of 2024. The grant will fund 15 local education foundations, emphasizing nursing and allied health tracks through work-based learning, healthcare career exploration, and industry certifications.

Since 2021, HCA Healthcare Foundation's Healthier Tomorrow Fund has committed over $20 million to community needs and health equity projects. The collaboration aims to address workforce shortages and provide meaningful learning opportunities for students.

HCA Healthcare, Inc. (NYSE:HCA) will present at the Jefferies Global Healthcare Conference on June 5, 2024, in New York. Investors can access the live webcast and presentation materials on the company's website.

Matterworks, Inc. announces the appointment of Jennifer M. Campbell, Ph.D. as Chief Scientific Officer and Niall O'Connor as Chief Technology Officer. Dr. Campbell brings 25 years of expertise in mass spectrometry and molecular analysis, while Mr. O'Connor is a product and technology leader in healthcare and life sciences. Their roles aim to propel Matterworks' AI platform and predictive biology applications forward.

HCA Healthcare, Inc. (NYSE: HCA) reports strong financial results for the first quarter of 2024, with revenues totaling $17.339 billion, net income of $1.591 billion, and adjusted EBITDA of $3.353 billion. Same facility admissions and emergency room visits increased, while inpatient surgeries rose and outpatient surgeries declined. The balance sheet shows cash and cash equivalents of $1.284 billion, total debt of $40.191 billion, and total assets of $56.962 billion. Cash flows from operating activities amounted to $2.469 billion. The Company repurchased shares and declared a quarterly cash dividend of $0.66 per share. Future dividends are expected to be funded by cash balances and cash flows from operations. The Company reaffirmed its 2024 estimated guidance ranges.